Krsnaa Diagnostics reports strong Q2 and H1 FY26 financial performance; addresses tax demand
Krsnaa Diagnostics announced robust Q2 and H1 FY26 financial results with increased revenue and profit, alongside an update on a tax demand which management believes will not have a material impact.
The announcement of financial results, especially showing growth, is a high-impact event for investors. The detailed financial figures provide crucial insight into the company's performance, while the resolution or ongoing appeal of a tax demand, even if deemed non-material by management, is also a significant disclosure.
The company reported significant year-over-year growth in both standalone and consolidated revenue and profit for the quarter and half year ended September 30, 2025. Although there is a tax demand, management asserts it will not have a material impact, contributing to an overall positive outlook on financial performance.
* Krsnaa Diagnostics Limited's Board of Directors met on November 07, 2025, to approve the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025. * Standalone Financial Highlights (Q2 FY26 vs Q2 FY25): * Revenue from operations increased to ₹182.88 crore (₹1,828.82 million) from ₹178.72 crore (₹1,787.22 million). * Profit for the period rose to ₹23.24 crore (₹232.39 million) from ₹21.97 crore (₹219.65 million). * Basic Earnings Per Share (EPS) improved to ₹7.12 from ₹6.80. * Standalone Financial Highlights (H1 FY26 vs H1 FY25): * Revenue from operations grew to ₹358.50 crore (₹3,584.97 million) from ₹341.89 crore (₹3,418.85 million). * Profit for the period increased to ₹42.80 crore (₹428.01 million) from ₹40.15 crore (₹401.46 million). * Basic EPS was ₹13.22 compared to ₹12.43. * Consolidated Financial Highlights (Q2 FY26 vs Q2 FY25): * Revenue from operations increased to ₹205.99 crore (₹2,059.91 million) from ₹186.34 crore (₹1,863.40 million). * Profit for the period rose to ₹23.95 crore (₹239.45 million) from ₹19.60 crore (₹195.96 million). * Basic EPS improved to ₹7.38 from ₹6.07. * Consolidated Financial Highlights (H1 FY26 vs H1 FY25): * Revenue from operations grew to ₹398.97 crore (₹3,989.69 million) from ₹356.57 crore (₹3,565.72 million). * Profit for the period increased to ₹44.47 crore (₹444.65 million) from ₹37.52 crore (₹375.17 million). * Basic EPS was ₹13.73 compared to ₹11.62. * The company has received assessment orders from Income Tax authorities with a demand of ₹51.39 crore (₹513.86 million) related to search assessment proceedings. The company has filed appeals and paid ₹3.93 crore (₹39.27 million) under protest, also requesting adjustment of ₹6.35 crore (₹63.50 million) from tax refunds. Management believes these demand orders are not tenable and will not have a material impact on the company's financial position or performance.
What to do with a filing like this
Krsnaa Diagnostics Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Krsnaa Diagnostics Limited. Read the original for the full detail.